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Abstract: The osteocyte network inside the bone matrix is of functional importance and osteocyte
cell death is a characteristic feature of pathological bone diseases. Osteocytes have emerged as
key regulators of bone tissue maintenance, yet maintaining their phenotype during in vitro culture
remains challenging. A 3D co-culture system for osteocytes with osteoblasts was recently presented,
enabling the determination of more physiological effects of growth factors on cells in vitro. MLO-Y4
cells were embedded within a type I collagen gel and cultured in the presence of surface MG-63 cells.
Co-culture was performed in the presence or absence of TGFβ3. Gene expression by quantitative PCR,
protein expression by fluorescent immunohistochemistry and cell viability tests were performed.
The 3D co-culture induced cell differentiation of MG-63 cells seen by increased type I collagen and
osteocalcin mRNA expression. TGFβ3 maintained osteocyte differentiation of MLO-Y4 cells during
co-culture as determined by stable E11 and osteocalcin mRNA expression till day 4. Interestingly,
most of the effects of TGFβ3 on co-cultured cells were serum-dependent. Also, TGFβ3 reduced cell
death of 3D co-cultured MLO-Y4 cells in a serum-dependent manner. This study shows that 3D
co-culture upregulates differentiation of MG-63 cells to a more mature osteoblast-like phenotype;
while the addition of TGFβ3 maintained the characteristic MLO-Y4 osteocyte-like phenotype and
viability in a serum-dependent manner.
Keywords: bone biology; osteoblast; osteocyte; three-dimensional (3D) co-culture; transforming
growth factor-beta 3 (TGFβ3)
1. Introduction
Members of the Transforming growth factor beta (TGFβ) super family mediate key events in
skeletal development and postnatal bone homeostasis, acting on osteoblasts, osteoclasts, as well as the
crosstalk between both cell types [1]. TGFβs are synthesized as large precursor molecules, containing
both the active peptide and a non-covalently bound latency-associated protein. In this latent form,
TGFβs are stored in vast amounts in the extracellular matrix (ECM) of bone [2–4]. Their release and
activation from the ECM is dependent upon the bone resorptive activity of osteoclasts at active sites
of bone remodelling [5]. Once released, the effects of TGFβs on osteoblasts are multifactorial and
dependent on their stage of differentiation [6]. It has long been known that TGFβs act on osteoblast
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progenitors as a chemoattractant, initiating their migration during a bone remodelling cycle, or in
the case of fracture repair towards sites of new bone formation [7]. TGFβ induces osteoblasts to
proliferate, differentiate and produce extracellular matrix [8,9]. However, the effects of TGFβ on cells
of the osteoblast lineage are complex and even though TGFβ increases osteoid production, it inhibits
mineralization of the produced matrix [10]. Consequently, type I collagen expression is stimulated by
TGFβ, while osteocalcin expression is inhibited by TGFβ [11].
During bone formation, some osteoblasts are encased and terminally differentiate further to
dendritic osteocytes. These lie within a three-dimensional (3D) fluid-filled lacuno-canalicular system
that spans through the entire bone matrix and predisposes osteocytes as the mechanosensoric cells
in bone tissue [12]. Recently, osteocytes have come to the spotlight of research projects and their
established multifunctionality ranges from regulation of phosphate homeostasis, to directing bone
turnover and even influencing distant tissue functions (for review see: [13,14]). With osteocytes being
buried alive within bone, osteocyte viability is of essential importance to the maintenance of bone
homeostasis. They are thought to be one of the longest living cells in our body. We have previously
shown that TGFβ3 is able to maintain osteocyte viability in an ex vivo culture of human cancellous
bone explants [15,16]. Within cancellous bone explants, it was demonstrated that the positive cell
survival effect by daily dynamic compressive load was enhanced by the addition of TGFβ3. Apart
from the clear advantage of a bone organ culture, namely the naturally occurring cell and matrix
interactions, the presence of a highly calcified extracellular matrix complicates investigations of cellular
reactions, the culture requires an advanced bioreactor setup and the maintenance of the cell culture
conditions is not trivial [17].
Discoveries on the in vitro effects of TGFβs on cultured osteoblast-like cells have been performed
mainly using monolayer cultures. Yet, (i) bone is a 3D tissue which is characterized by extensive
cell-to-cell and cell-to-matrix connectivity, that is, the dendritic osteocyte network embedded in the
bone matrix interacting with surface osteoblasts and (ii) it is not yet clear if these could alter the effect,
effect size or timing of cellular responses to growth factors. The effects of growth factors in vivo will
also be defined by such cellular interactions. Vazquez et al. [18] described a 3D co-culture method for
surface osteoblast-like cells and collagen-matrix embedded osteocyte-like cells. The authors presented
a system consisting of osteoblasts layered on top of a type I collagen gel, which contains 3D-embedded,
interconnected osteocytes. Within the model system both cell types were shown to express appropriate
phenotypic markers for up to 7 days and osteocytes were found to respond to mechanical stimulation.
This allows the effects of cytokines on osteoblasts and on osteocytes to be tested in the presence of a
3D osteoblast-osteocyte-collagen matrix connectivity.
In this study, we aim to investigate the effects of TGFβ3 on both osteoblasts (MG-63 cell line) and
osteocytes (MLO-Y4 cell line) within a 3D co-culture. Moreover, a defined serum-free (SF) culture
medium was created to facilitate the serum-independent investigation of the cellular effects of TGFβ3
on cell phenotype and viability.
2. Results
2.1. TGFβ3 Maintained Runx2 Expression in Co-Cultured MG-63 Osteoblast-Like Cells and Did not Affect the
Increase in Osteocalcin Expression
To investigate the effect of TGFβ3 on MG-63 osteoblast-like cells within a 3D osteoblast-osteocyte
co-culture model, the expression of Runx2 and osteocalcin mRNA levels were evaluated. Runx2 is the
major osteoblast transcription factor expressed early in osteoblast differentiation, while osteocalcin
is expressed in large amounts by late osteoblasts, as well as early osteocytes and coincides with
mineralization of the extracellular matrix [19]. All groups demonstrated similar Runx2 expression
except for FCS alone, where Runx2 levels increased steadily over time, leading to a significantly lower
Runx2 expression in the MG-63 cell line with TGFβ3 + FCS compared to FCS alone at day 4 (Figure 1A).
Osteocalcin expression generally increased over time in co-cultured MG-63 osteoblast-like cells,
with SF cultures exhibiting the largest increase. TGFβ3 did not influence osteocalcin mRNA expression
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(Figure 1B). This result suggests overall induction of osteoblast differentiation during culture, with
the highest level of osteocalcin expression seen on day 4 using SF media alone. On day 4, only the
addition of TGFβ to SF medium led to a non-significant increase in osteocalcin expression compared
to significant increases in all other groups.
Serum-dependency: TGFβ3 prevented the increase in Runx2 expression in MG-63 cells during
culture. This effect was only seen in the presence of FCS. While for osteocalcin expression, the effect of
TGFβ3 was mostly serum-independent.
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Figure 1. Fold-change in relative gene expression for (A) Runx2 (CT: 18–22) and (B) osteocalcin
(CT: 18–24) in co-cultured MG-63 osteoblast-like cells. Gene expression levels were normalized to
GAPDH and were made relative to cultures in αMEM + FCS on day 2. The dCT data was used for
statistical analysis: normally distributed, one-way ANOVA with Tukey (n = 3–4 replicates/experiment,
3 experiments). Statistical significance was determined as p < 0.05; *: comp r d to different media on
that day; #: compared to same m dium group on day 2. Bar charts show the average fold-change as
well as the standard error of the mean.
2.2. TGFβ3 Maintained Osteocalcin Expression in 3D Co-Cultured MLO-Y4 Cells Serum-Independently and
E11 Expressio in a Serum-Dependent Manner
To investigate the MLO-Y4 osteocyte phenotype during 3D co-culture with MG-63 osteoblast-like
cells, we investigated mRNA expression of the late osteoblast marker osteocalcin and the early
osteocyte marker E11. MLO-Y4s osteocalcin expression was maintained until day 4 by TGFβ3 in
an FCS-independent manner, while SF-medium alone led t higher osteocalcin expression levels on
day 2 and day 4 (Figure 2A). By day 6, osteocalcin expression was reduced in FCS-cultured MLO-Y4
osteocyte-like cells compared to SF alone. This indicates that osteocalcin expression is reduced in the
presence of serum or TGFβ.
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Figure 2. Fold-change in relative gene expression for (A) osteocalcin (CT: 18–23) and (B) E11 (CT: 19–21)
in 3D co-cultured MLO-Y4 osteocyte-like cells. Gene expression levels were normalized to 18SrRNA
and made relative to αMEM + FCS on day 2. The dCT data was used for statistical analysis: normally
distributed, one-way ANOVA with Tukey (n = 3–4 replicates/experiment, 3 experiments). Statistical
significance was determined as p < 0.05; *: compared to different media on that day; #: compared to
same medium group on day 2. Bar charts show the average fold-change as well as the standard error
of the mean.
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The addition of TGFβ3 to serum-containing medium maintained E11 expression at a constant level
until day 6. In all other groups, E11 mRNA expression significantly decreased during 3D co-culture in
FCS-cultured MLO-Y4 cells (Figure 2B).
Serum-dependency: In the absence of serum TGFβ3 prevented the increase in osteocalcin
expression in MLO-Y4 osteocyte-like cells. While TGFβ3’s effect on maintaining E11 expression
was only seen in the presence of serum.
2.3. TGFβ3 Regulated Type I Collagen Expression in Co-Cultured MG-63 Osteoblast-Like Cells
Type I collagen mRNA expression was solely evaluated in co-cultured MG-63 osteoblast-like
cells, here TGFβ3 significantly affected collagen synthesis (Figure 3). Type I collagen was expressed at
highest levels in the presence of TGFβ3. Yet, for serum-containing culture medium significance with
TGFβ3 was reached on day 4, while SF culture showed significance upon TGFβ3 addition on day 2
(p = 0.045) (Figure 3).
Serum-dependency: TGFβ3 lead to higher type I collagen mRNA expression by MG-63
osteoblast-like cells in a serum-independent manner.
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protein expression by co-cultured MG-63 osteoblast-like cells. Labelling revealed a difference in the 
onset of newly formed collagenous matrix deposition by the co-cultured MG-63s depending upon 
TGFβ3 presence. However, even though type I collagen mRNA expression was increased by TGFβ3 
addition; on a protein level type I collagen synthesis was delayed if TGFβ3 was added to FCS or SF 
medium. ProCI was detected on culture day 2 on surface MG-63 osteoblast-like cells cultured in FCS 
or SF medium but only detected in TGFβ3 containing cultures at day 6 (Representative images at 
culture day 4 are shown in Figure 4). Co-cultured osteocytes were not positive for ProCI (Figure 4E). 
Serum-dependency: The effect of TGFβ3 on type I collagen protein expression was serum-
independent. 
i re 3. l -c a e i relati e e e ex ressi f t e I c lla e ( : 21–31) i c -c lt re -63
ste l st-li e cells. Gene expression levels were normalized to GAPDH and were made relative
to α EM + FCS on day 2. The dCT data was used for statistical a alysis: normally istributed,
one-way ANOVA with Tukey (n = 3–4 replicat s/experim nt, 3 experiments). Statistical significance
was determined as p < 0.05; *: compared to different media on that day; #: compared to sa i
t r f t e .
Immunocytochemical labelling of ProCI was used as qualitative analysis of type I collagen protein
expression by co-cultured MG-63 osteoblast-like cells. Labelling revealed a difference in the onset
of newly formed collagenous matrix deposition by the co-cultured MG-63s depending upon TGFβ3
presence. However, even though type I collagen mRNA expression was increased by TGFβ3 addition;
on a protein level type I collagen synthesis was delayed if TGFβ3 was added to FCS or SF medium.
ProCI was detected on culture day 2 on surface MG-63 osteoblast-like cells cultured in FCS or SF
medium but only detected in TGFβ3 containing cultures at day 6 (Representative images at culture
day 4 are shown in Figure 4). Co-cultured osteocytes were not positive for ProCI (Figure 4E).
Serum-dependency: The effect of TGFβ3 on type I collagen protein expression was
serum-independent.
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C-terminal propeptide of type I collagen (Alexa 594, red) in combination with DAPI nuclear staining
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G-63 osteoblast-like cells on culture day 4 (A–D). (A) αMEM + FCS, (B) α EM SF, (C) αMEM +
FCS + TGFβ3, and (D) αMEM SF + TGFβ3. ProCI labelling in TGFβ3-containing medium was not yet
present on day 4. MLO-Y4 osteocyte-like cells in co-culture demonstrated dendritic phenotype, these
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2.4. TGFβ3 Reduced Cell Death of MLO-Y4 Osteocyte-Like Cells in a Serum-Dependent Manner
E11 is an early osteocyte marker gene, associated with the development of the dendrites formed
by osteocytes [20]. The connectivity of osteocytes within bone is crucial for osteocyte viability [21,22].
As TGFβ3 was found to maintain E11 gene expression of MLO-Y4 osteocyte-like cells during 3D
co-culture, the influence of TGFβ3 on cell survival was investigated by LDH and TUNEL assays.
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A qualitative LDH activity assay showed the presence of viable MG-63 cells and MLO-Y4 cells
under all culture conditions (data not shown). Quantitative TUNEL assay was performed to evaluate
the effect of TGFβ3 on MLO-Y4 cell death within the 3D osteoblast-osteocyte co-culture system.
TGFβ3 significantly increased MLO-Y4 osteocyte-like cell survival (Figure 5). Co-culture of MLO-Y4
osteocyte-like cells in medium containing both FCS and TGFβ3 showed the overall lowest cell death
on day 4 of culture. The addition of TGFβ3 to SF medium did not increase MLO-Y4 cell viability.
Serum dependency: TGFβ3 reduced cell death of MLO-Y4 osteocyte-like cells at a later stage of
co-culture only in the presence of serum.
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Figure 5. Graph to illustrate the effect of TGFβ3 on the viability of 3D co-cultured MLO-Y4
osteocyte-like cells. Data—collected on culture day 4—was normally distributed (n = 3
replicates/experiment, 3 experiments): one-way ANOVA and Tukey were used as statistical analysis.
Statistical significance was defined as * p < 0.05. Bar chart shows the average osteocyte death and
standard error of the mean.
3. Discussion
Within this paper we present that TGFβ3 affects differentiation and viability of MG-63
osteoblast-like cells and MLO-Y4 osteocyte-like cells within a 3D co-culture model. The co-culture
facilitates the characteristic expression of type I collagen and osteocalcin mRNA by MG-63
osteoblast-like cells cultured as surface cells on top of a type I collagen gel, indicating that these
cells undergo differentiation to a more mature osteoblast state during co-culture. At the same time,
TGFβ3 maintained E11 expression of the embedded MLO-Y4 osteocyte-like cells. Most effects seen by
TGFβ3 in co-culture were found to be serum-dependent, as was the prevention of apoptosis by TGFβ3
in co-cultured MLO-Y4 osteocyte-like cells.
Previous work has shown that the stimulatory effect of TGFβ3 on type I collagen and DNA
synthesis, demonstrated previously in foetal rat osteoblast-enriched cultures, is more potent than using
TGFβ1 [23]. The effect on type I collagen synthesis by TGFβs might be due to an increase in type I
collagen mRNA stability, mRNA expression, or enhanced type I collagen synthesis [8,24]. Within this
co-culture system we also demonstrated a significant up-regulation of type I collagen mRNA in the
presence of TGFβ3. However, type I collagen protein synthesis appeared to be delayed by TGFβ3
and was only detectable at day 6. Thus, TGFβ3 increased type I collagen mRNA expression but must
also activate post-transcriptional or post-translational processes to reduce pro-collagen synthesis or
enhance pro-collagen degradation.
Within the 3D osteoblast-osteocyte co-culture, FCS-containing medium increased Runx2 mRNA
expression in MG-63 osteoblast-like cells but this was prevented by the addition of TGFβ3. The results
of several studies suggest that TGFβ induces initial pre-osteoblast proliferation and differentiation,
while inhibiting terminal differentiation into a more mature osteoblast phenotype [1,6,24]. The
down-regulation of Runx2 mRNA by TGFβ in mice calvaria-derived osteoblasts in the presence
of serum was demonstrated previously [11]. Within our 3D co-culture study, we detected a
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down-regulation of Runx2 mRNA also exclusively in the presence of serum. The relative expression
level of Runx2 caused by culture in αMEM + FCS + TGFβ3, or αMEM SF ± TGFβ3 might be seen as a
transcriptional basal level within this co-culture system.
In contrast to previous mono-culture studies in 2D reporting the down-regulation of osteocalcin
by TGFβ addition [11], within our 3D co-culture study TGFβ3 did not decrease osteocalcin mRNA in
co-cultured MG-63 osteoblast-like cells. An increase in osteocalcin mRNA expression was detected
over time in 3D co-cultured MG-63 osteoblast-like cells. The relative osteocalcin expression in the
osteoblast-like cells was highest in serum free medium without the addition of the growth factor. On
the contrary, embedded MLO-Y4 osteocyte-like cells significantly down-regulated osteocalcin mRNA
expression in serum containing medium with or without TGFβ3.
E11 expression is a known marker for early osteocytes and its expression is significantly associated
with dendrite formation and osteocyte responsiveness to fluid flow shear stress [20]. The MLO-Y4
osteocyte-like cell line as used in this study is characterized by a high expression level of E11 [25]. In
this 3D co-culture investigation, we found that TGFβ3 maintained the expression of E11 mRNA in
a serum-dependent manner, suggesting that TGFβ3 maintains the differentiation level of MLO-Y4
cells. E11 is an early osteocyte marker gene, associated with the development of the dendrites formed
by osteocytes [20]. The connectivity of osteocytes via their dendritic network in bone is crucial for
osteocyte viability [21,22].
The addition of TGFβ3 to αMEM + FCS significantly improved MLO-Y4 osteocyte survival. This
effect was not visible in SF medium with TGFβ3. Suggesting that the combination of TGFβ3 with
FCS is necessary to allow for superior cell viability during culture of the 3D construct. Karsdal et al.
reported that TGFβ1 is able to rescue matrix metalloprotease-induced apoptosis of MC3T3-E1 cells [26].
MT1-MMP activation of latent TGFβ1 seems to be responsible for the maintenance of osteoblast
viability during differentiation into osteocytes [27,28]. The influence of TGFβ3 on osteocyte survival
was also demonstrated in an ex vivo culture system for human cancellous bone [13]. In addition,
TGFβ has been shown to support osteocyte functionality [29]. To our knowledge, these previously
reported cell culture experiments were performed in the presence of serum within the culture medium.
Therefore, our results on the viability of 3D co-cultured MLO-Y4 osteocyte-like cells in αMEM + FCS +
TGFβ3 confirms these previous studies.
Limitations: In addition to the growth factor and serum-dependent effects described, we have to
acknowledge and mention that the serum-free medium used could also influence cellular responses.
While we could only compare to FCS, which by itself is a mixture of growth factors and hormones,
the insulin-transferrin-selenium-lipid supplementation used as serum-free medium contains potent
molecules affecting osteoblast-lineage cell behaviour. However, this supplementation is widely
established to be used in serum-free media and is needed to allow for cell viability.
Furthermore, we acknowledge the use of cell lines from two different donor species in our study.
While it was our intention to be conform to the previously established protocol [18] using these, future
studies should use cell lines derived from the same species and verify the results using primary
derived cells.
Here we present for the first time the effects of TGFβ3 on 3D co-cultured MG-63 osteoblast-like
cells and MLO-Y4 osteocyte-like cells. We were able to show that MG-63 cell differentiation was
increased during 3D co-culture into a more mature osteoblast-like phenotype, and TGFβ3 maintained
the characteristic MLO-Y4 osteocytic differentiation, while increasing MLO-Y4 cell survival in the
3D co-culture. The later effect confirmed our previous results of TGFβ3 on osteocyte viability in 3D
cancellous bone explants cultured ex vivo in a bioreactor. The effects presented here were mostly found
to be serum-dependent. Yet, further studies would be required to investigate the serum-dependency
and prolong culture conditions beyond six days. The optimum conditions derived from the multiple
groups investigated in this study needs to be confirmed using primary human cells.
In conclusion, our study utilizes a 3D co-culture model of osteoblast-osteocyte connectivity in 3D
to approximate the signalling observed within bone, while providing a system that is easier to apply.
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4. Materials and Methods
4.1. Cell Culture
Three independent co-culture experiments were performed using both MG-63 osteoblastic and
MLO-Y4 osteocyte-like cells. Prior to experiments the human osteoblast cell line MG-63 was cultured
in monolayer until confluence. Cells from passage 16–20 were used for co-culture experiments at 70%
confluence. The mouse osteocyte cell line MLO-Y4 was kindly provided by L.F. Bonewald [25]. Cells
were cultured in monolayer and used for experiments between passage 39 and 44. The MLO-Y4 cell
line was maintained as advised by the lab of L.F. Bonewald and phenotypic criteria of dendricity and
high osteocalcin and E11 expression were utilized.
MG-63–MLO-Y4 co-cultures were prepared in type I collagen gels as previously described [18].
Briefly, 50 mg type I collagen was dissolved over night at 4 ◦C in 7 mM acetic acid to produce 2.5 mg
type I collagen per ml solution. DMEM (10×, Gibco, Waltham, MA, USA) was mixed 1:1 with deionized
water containing 22 g/L NaHCO3. This 5× DMEM was added 1:4 to the 2.5 mg/mL type I collagen on
ice. The mixture was neutralized with 1 M Tris base (pH = 12.6) prior to the addition of cells. MLO-Y4
cells were seeded at a density of 1.5 × 106 cells/mL into 250 µL gels. Each gel was prepared within one
well of a 24-well plate. Gels were left to polymerize at 37 ◦C for 1 h. A layer of 1.6× 105 MG-63 cells was
seeded on top of each gel. Co-cultures were performed cultured for 6 days in either (i) αMEM (Gibco) +
5% foetal calf serum (FCS; Biowest, Nuaillé, France) + Pen/Strep (10 kU Penicillin: 10 mg Streptomycin;
Invitrogen, Waltham, MA, USA), or (ii) αMEM + insulin-transferrin-selenium-lipid supplementation
(Gibco; serum free (SF) culture) + Pen/Strep—with or without the addition of 15 ng/mL TGFβ3
(Novartis Pharma AG, Basel, Switzerland). Each media group contained 3–4 replicates per time point
(day 2, day 4 and day 6). Co-cultures were supplied with 1 mL media per gel. Media was exchanged
every 48 h.
4.2. RT-qPCR
RNA samples were taken from co-cultures every 48 h, starting on day 2. Cell lysis of osteoblasts
and osteocytes was performed separately using TRIzol as previously described (Molecular Research
Centre, Cincinnati, OH, USA) [18]. Briefly, gels were incubated first for 10 s with TRIzol to collect
the surface osteoblasts, prior to a separate TRIzol incubation to collect the embedded osteocytes.
Osteoblast and osteocyte RNA samples were isolated according to manufactures instructions. Reverse
transcription (RT) was performed with 0.5 µg RNA per reaction using random hexamers and
Superscript III (all Invitrogen) according to manufacturer’s protocol. Quantitative polymerase
chain reaction (qPCR) was performed on a Stratagene MX3000 using incorporation of Sybr®green
(Sigma-Aldrich, St. Louis, MO, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
chosen as housekeeping gene for the human cell line MG-63, as its expression was the least affected by
the treatments. 18S ribosomal RNA (18SrRNA) was chosen as the MLO-Y4 housekeeping gene for
the same reason. Expression levels of osteoblastic and osteocytic marker genes (Table 1) were made
relative to levels at day 2 samples in αMEM + FCS after normalization to housekeeping genes.
Table 1. RT-qPCR was performed to investigate relative expression levels of human GAPDH, human
Runx2 and human osteocalcin in MG-63, as well as mouse 18SrRNA, mouse E11 and mouse osteocalcin
in MLO-Y4. The table shows the primer sequences used.
Gene Forward Primer Reverse Primer
human GAPDH GGT ATC GTG GAA GGA CTC ATG A GGC CAT CCA CAG TCT TCT G
human Runx2 GTG GAC GAG GCA AGA GTT TC TTC CCG AGG TCC ATC TAC TG
human osteocalcin GGC AGC GAG GTA GTG AAG AG GAT CCG GGT AGG GGA CTG
human type I collagen CCC TGG AAA GAA TGG AGA TGA T ACT GAA ACC TCT GTG TCC CTT CA
mouse 18SrRNA GCA ATT ATT CCC CAT GAA CG GGC CTC ACT AAA CCA TCC AA
mouse E11 AAG ATG GCT TGC CAG TAG TCA GGC GAG AAC CTT CCA GAA AT
mouse osteocalcin CAGACAAGTCCCACACAGCA GAA AT
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4.3. Immunocytochemical Staining
The presence of β-actin and the C-terminal propeptide of type I collagen (ProCI; M38 DSHB) was
detected via immunocytochemistry. Co-cultures were fixed in 1% paraformaldehyde (Sigma-Aldrich,
St. Louis, MO, USA) in 0.05 M phosphate buffered saline for 30 min at 4 ◦C on culture days 2, 4
or 6. Cryosections (thickness of 10 µm) from the central region of the co-cultures were prepared.
Fluorescence labelling of β-actin (phalloidin, Alexa 488), together with ProCI (Alexa 594; all Invitrogen)
and DAPI was performed.
4.4. Viability and Cell Death
Cell viability of osteoblasts and osteocytes within co-cultures was qualitatively determined
using the lactate dehydrogenase assay (Sigma-Aldrich). Therefore, unfixed cryo-sections (12 µm)
from co-cultures on culture day four were prepared. The LDH assay on unfixed cryo-sections was
performed as previously described [30].
Cell death was quantified using the Terminal deoxy nucleotidyl transferase dUTP-nick-end-
labelling (TUNEL) assay. Seven images per media group and per time point were taken from the
centre region of the collagen gels. Dead osteocytes and residual (alive) osteocytes were manually
counted and percentages calculated. Controls were performed according to manufactures instructions
(DeadEnd™ Fluorometric TUNEL System was from Promega, Fitchburg, MA, USA). The positive
control was pre-digested with DNase I prior to TUNEL labelling. The negative control was performed
without the addition of the Terminal Deoxynucleotidyl Transferase enzyme.
4.5. Statistical Analysis
Statistical analyses were carried out using SPSS 16.0 software package (IBM, New York, NY, USA).
The analysis of the RT-qPCR data was performed on the dCT datasets. Normal distribution was
confirmed by Kolmogorov–Smirnov test. One-way ANOVA and Tukey post-hoc tests were used to
compare the data sets. Primary outliers and extremes were determined as being numerically distant
from the rest of the data (outliers > 1.5 times the interquartile range, extremes > 3 time the interquartile
range) and were removed from the analysis.
The TUNEL assay data was not normally distributed. Therefore, Mann-Whitney Rank Sum Test
and Bonferroni post-hoc test were used as statistical analyses. A p-value of below 0.05 was considered
statistically significant.
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